In conclusion, our study provides a comparative analysis of N-glycosylation signatures between eCCA and iCCA and identifies DPM1 as a key regulator of tumor-associated glycopeptides and immune suppression in eCCA, offering new insights into its pathogenesis. The gene discussed is DPM1; the disease is neoplasm.